COBRO VENTURES OPPORTUNITY FUND L.P. 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-06-15 08:31 am Sale |
2021-06-14 | 13D | C4 Therapeutics, Inc. CCCC |
COBRO VENTURES OPPORTUNITY FUND L.P. | 2,127,999 4.900% |
-2,213,931 (-50.99%) |
Filing |
| 2020-10-16 4:09 pm Purchase |
2020-10-06 | 13D | C4 Therapeutics, Inc. CCCC |
COBRO VENTURES OPPORTUNITY FUND L.P. | 4,341,930 10.100% |
4,341,930 (New Position) |
Filing |